跳至主要内容
临床试验/NCT02292615
NCT02292615Unknown不适用

Application of Integrated MR-PET in Patients With Gynecologic Cancers

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
220
试验地点
1
主要终点
The imaging biomarkers determined by MR-PET

研究概览

简要总结

In this prospective cohort study, patients with newly diagnosed gynecologic cancers (including cervical, endometrial, and ovarian cancers) and patients with suspicious recurrent gynecologic cancers will be enrolled. The study period is two years and the estimated patient number is about 220. Patients will undergo image study before and after treatment. The diagnostic accuracy of MR-PET in cancer staging and the potential image biomarkers to monitor treatment response and predict treatment outcome will be investigated.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Group 1: Patients with newly diagnosed gynecologic cancers (including cervical, endometrial, and ovarian cancers).
  • Group 2: Patients with suspicious recurrent gynecologic cancers (including cervical, endometrial, and ovarian cancers).
  • Group 3: Patients with ovarian cancer who had debulking surgery and are going to receive adjuvant chemotherapy.

排除标准

  • Age <20 or >90 years old
  • Contraindication for MRI:
  • Contraindication for MR contrast medium (Cre > 2.0)
  • History of other malignancy
  • Prior arthroplasty of hip or pelvic bone surgery with metallic fixation (may cause artifacts on MRI)
  • Pregnant or lactating women

结局指标

主要结局

The imaging biomarkers determined by MR-PET

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验